Dr. Litzow on Assessing Minimal Residual Disease in Patients With ALL Targeted Oncology 1:16 10 years ago 184 Далее Скачать
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 3:19 7 years ago 61 Далее Скачать
The role of MRD in ALL: what defines a complete response? VJHemOnc – Video Journal of Hematology & HemOnc 3:35 6 years ago 463 Далее Скачать
The importance of MRD assessment in all phases of ALL treatment VJHemOnc – Video Journal of Hematology & HemOnc 0:46 6 years ago 169 Далее Скачать
The use of immunophenotyping to assess minimal residual disease (MRD) in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:23 8 years ago 399 Далее Скачать
MRD negativity in ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:57 5 years ago 839 Далее Скачать
Significance of MRD negativity in Ph-negative ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:01 4 years ago 257 Далее Скачать
How is minimal residual disease managed in patients with ALL? ecancer 4:47 4 years ago 132 Далее Скачать
What is MRD, or Minimal Residual Disease? International Myeloma Foundation 3:44 6 years ago 7 684 Далее Скачать
A Roadmap for MRD Testing in B-cell ALL: Prepare the Care Team ACCCvision 0:34 3 years ago 41 Далее Скачать
Minimal residual disease (MRD) in CLL: Is it clinically relevant? HMP Education 21:09 6 years ago 1 744 Далее Скачать
MRD in pediatric ALL: clinical evidence, treatment decisions & outcomes VJHemOnc – Video Journal of Hematology & HemOnc 2:04 5 years ago 497 Далее Скачать
MRD assessment for surveillance post-treatment in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:26 3 years ago 287 Далее Скачать
The utility of measurable residual disease (MRD) assessment in acute myeloid leukemia (AML) VJHemOnc – Video Journal of Hematology & HemOnc 2:18 7 years ago 164 Далее Скачать
Approaches to and the use of MRD in ALL VJHemOnc – Video Journal of Hematology & HemOnc 5:17 2 years ago 503 Далее Скачать
